本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Mereo Biopharma Group Plc

0.2800
+0.035414.47%
盤後0.2799-0.0001-0.04%19:53 EDT
成交量:510.99萬
成交額:141.02萬
市值:4,455.69萬
市盈率:-1.60
高:0.2932
開:0.2600
低:0.2600
收:0.2446
52周最高:2.37
52周最低:0.2000
股本:1.59億
流通股本:1.31億
量比:3.83
換手率:3.90%
股息:- -
股息率:- -
每股收益(TTM):-0.1753
每股收益(LYR):-0.2627
淨資產收益率:-67.85%
總資產收益率:-42.46%
市淨率:1.56
市盈率(LYR):-1.07

資料載入中...

2020/07/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/09

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/15

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/06/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/03/27

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/18

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/12

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers
2020/03/09

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/03/06

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/06

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers
2020/03/02

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/18

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/02/18

招股説明書

Registration statement for certain foreign private issuers